The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners developing next-generation con ...

Leishmaniasis is present in approximately 200 countries worldwide, being a major public health problem primarily in the ...

ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.

Moderna, best known for its COVID mRNA vaccine, is developing an investigational mRNA vaccine against the rare Bundibugyo ...

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and PreventionSK bioscience is jointly ...

For the first time, an AI-designed vaccine has passed a human clinical trial.